Tag: Medical Device Investing

Home » Medical Device Investing
Cleo Diagnostics
Post

Cleo Diagnostics (ASX:COV) Investor Overview

Overview A medical technology company based in Australia, Cleo Diagnostics (ASX:COV) is revolutionising women’s healthcare with its disruptive cancer detection platform technology, through a simple blood test that can accurately detect ovarian cancer early – the leading cause of cancer-related deaths among women. Approximately 50 percent of women will die within five years of an...

Women representing early cancer detection
Post

Cleo Diagnostics (ASX:COV) Investor Overview

Overview A medical technology company based in Australia, Cleo Diagnostics (ASX:COV) is revolutionising women’s healthcare with its disruptive cancer detection platform technology, through a simple blood test that can accurately detect ovarian cancer early – the leading cause of cancer-related deaths among women. Approximately 50 percent of women will die within five years of an...

Avricore Grants Options
Post

Avricore Grants Options

AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) today announces that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 1,625,000 common shares to its directors, officers, employees and consultants at an exercise price of CAD $0.28 per common share. All Options were granted...